STUDY SEARCH RESULTS

1 study found for your search request:  6194-006

Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)
Condition: Systemic Lupus Erythematosus
Minimum Age: 18 years, Maximum Age: 75 years
Gender: All
Study ID: NCT06161116
Status: Terminated (Halted Prematurely)




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site